55 related articles for article (PubMed ID: 8709093)
1. 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents.
Henke BR; Willson TM; Sugg EE; Croom DK; Dougherty RW; Queen KL; Birkemo LS; Ervin GN; Grizzle MK; Johnson MF; James MK
J Med Chem; 1996 Jul; 39(14):2655-8. PubMed ID: 8709093
[No Abstract] [Full Text] [Related]
2. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
Henke BR; Aquino CJ; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; Hirst GC; James MK; Johnson MF; Queen KL; Sherrill RG; Sugg EE; Suh EM; Szewczyk JW; Unwalla RJ; Yingling J; Willson TM
J Med Chem; 1997 Aug; 40(17):2706-25. PubMed ID: 9276016
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger".
Aquino CJ; Armour DR; Berman JM; Birkemo LS; Carr RA; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Head JE; Hirst GC; James MK; Johnson MF; Miller LJ; Queen KL; Rimele TJ; Smith DN; Sugg EE
J Med Chem; 1996 Jan; 39(2):562-9. PubMed ID: 8558528
[TBL] [Abstract][Full Text] [Related]
4. 3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonists.
Willson TM; Henke BR; Momtahen TM; Myers PL; Sugg EE; Unwalla RJ; Croom DK; Dougherty RW; Grizzle MK; Johnson MF; Queen KL; Rimele TJ; Yingling JD; James MK
J Med Chem; 1996 Jul; 39(15):3030-4. PubMed ID: 8709137
[TBL] [Abstract][Full Text] [Related]
5. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
Sherrill RG; Berman JM; Birkemo L; Croom DK; Dezube M; Ervin GN; Grizzle MK; James MK; Johnson MF; Queen KL; Rimele TJ; Vanmiddlesworth F; Sugg EE
Bioorg Med Chem Lett; 2001 May; 11(9):1145-8. PubMed ID: 11354363
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.
Hirst GC; Aquino C; Birkemo L; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Henke B; James MK; Johnson MF; Momtahen T; Queen KL; Sherrill RG; Szewczyk J; Willson TM; Sugg EE
J Med Chem; 1996 Dec; 39(26):5236-45. PubMed ID: 8978852
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
8. Clozapine derived 2,3-dihydro-1H-1,4- and 1,5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing.
Hussenether T; Hübner H; Gmeiner P; Troschütz R
Bioorg Med Chem; 2004 May; 12(10):2625-37. PubMed ID: 15110844
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists.
Woltering TJ; Wichmann J; Goetschi E; Adam G; Kew JN; Knoflach F; Ballard TM; Huwyler J; Mutel V; Gatti S
Bioorg Med Chem Lett; 2008 Apr; 18(8):2725-9. PubMed ID: 18374569
[TBL] [Abstract][Full Text] [Related]
10. Dose-response effects of PEGylated cholecystokinin on the behavioral satiety sequence.
Verbaeys I; León-Tamariz F; De Buyser K; Buyse J; Decuypere E; Pottel H; Cokelaere M
Physiol Behav; 2009 Aug; 98(1-2):198-204. PubMed ID: 19465039
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin antagonistic activities of loxiglumide.
Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
[TBL] [Abstract][Full Text] [Related]
13. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents.
Gourcerol G; Million M; Adelson DW; Wang Y; Wang L; Rivier J; St-Pierre DH; Taché Y
Peptides; 2006 Nov; 27(11):2811-9. PubMed ID: 16934368
[TBL] [Abstract][Full Text] [Related]
14. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
Ghanekar D; Hadac EM; Holicky EL; Miller LJ
J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827
[TBL] [Abstract][Full Text] [Related]
15. Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors.
McDonald IM; Austin C; Buck IM; Dunstone DJ; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Pether MJ; Spencer J; Wright PT; Adatia T; Bashall A
J Med Chem; 2006 Apr; 49(7):2253-61. PubMed ID: 16570921
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepines as potent and selective bradykinin B1 antagonists.
Wood MR; Kim JJ; Han W; Dorsey BD; Homnick CF; DiPardo RM; Kuduk SD; MacNeil T; Murphy KL; Lis EV; Ransom RW; Stump GL; Lynch JJ; O'Malley SS; Miller PJ; Chen TB; Harrell CM; Chang RS; Sandhu P; Ellis JD; Bondiskey PJ; Pettibone DJ; Freidinger RM; Bock MG
J Med Chem; 2003 May; 46(10):1803-6. PubMed ID: 12723943
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
Bellier B; McCort-Tranchepain I; Ducos B; Danascimento S; Meudal H; Noble F; Garbay C; Roques BP
J Med Chem; 1997 Nov; 40(24):3947-56. PubMed ID: 9397175
[TBL] [Abstract][Full Text] [Related]
18. Benzotriazonine as a new core structure for the design of CCK-receptor antagonists.
Escherich A; Escrieut C; Fourmy D; Moroder L
J Pept Sci; 1999 Mar; 5(3):155-8. PubMed ID: 10323559
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
Hayes MR; Savastano DM; Covasa M
Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
[TBL] [Abstract][Full Text] [Related]
20. Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor.
Foltz M; Ansems P; Schwarz J; Tasker MC; Lourbakos A; Gerhardt CC
J Agric Food Chem; 2008 Feb; 56(3):837-43. PubMed ID: 18211011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
